{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:24:15Z","timestamp":1773933855671,"version":"3.50.1"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22508091"],"award-info":[{"award-number":["22508091"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013066","name":"Key Scientific Research Project of Colleges and Universities in Henan Province","doi-asserted-by":"publisher","award":["25B350004"],"award-info":[{"award-number":["25B350004"]}],"id":[{"id":"10.13039\/501100013066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["252300421379"],"award-info":[{"award-number":["252300421379"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.neuropharm.2025.110808","type":"journal-article","created":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T06:38:31Z","timestamp":1765694311000},"page":"110808","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cftr nominates a novel therapeutic target for Alzheimer's disease: Evidence from integrative omics and in vitro validation"],"prefix":"10.1016","volume":"286","author":[{"given":"Hao-Ran","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Zhuo","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu-Yao","family":"Yun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Feng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang-Yang","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guan-Hua","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Bin","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Mei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie-Jian","family":"Kou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2025.110808_bib1","series-title":"Multi-Omics Data Integration Reveals Clinically Meaningful Molecular Profiles of Alzheimer Disease","author":"Abdallah","year":"2021"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110808_bib2","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/fcp.12654","article-title":"The contributions of metabolomics in the discovery of new therapeutic targets in alzheimer's disease","volume":"35","author":"Altine-Samey","year":"2021","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110808_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.701282","article-title":"Activation of NLRP3 inflammasome and onset of alzheimer's disease","volume":"12","author":"Bai","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2025.110808_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101619","article-title":"Oxidative stress: the core pathogenesis and mechanism of alzheimer's disease","volume":"77","author":"Bai","year":"2022","journal-title":"Ageing Res. Rev."},{"issue":"29","key":"10.1016\/j.neuropharm.2025.110808_bib5","doi-asserted-by":"crossref","first-page":"22299","DOI":"10.1074\/jbc.M109.098566","article-title":"Loss of cystic fibrosis transmembrane conductance regulator function enhances activation of p38 and ERK MAPKs, increasing interleukin-6 synthesis in airway epithelial cells exposed to Pseudomonas aeruginosa","volume":"285","author":"Berube","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"13","key":"10.1016\/j.neuropharm.2025.110808_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241310678","article-title":"Tissue-specific regulation of CFTR gene expression","volume":"24","author":"Blotas","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110808_bib7","article-title":"Substance P and alzheimer's disease: emerging novel roles","author":"Cinzia","year":"2016","journal-title":"Curr. Alzheimer Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110808_bib8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13195-021-00814-7","article-title":"An integrative multi-omics approach reveals new central nervous system pathway alterations in alzheimer's disease","volume":"13","author":"Clark","year":"2021","journal-title":"Alzheimers Res. Ther."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110808_bib9","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/imm.13336","article-title":"NLR family pyrin domain containing 3 (NLRP3) and caspase 1 (CASP1) modulation by intracellular Cl - concentration","volume":"163","author":"Clauzure","year":"2021","journal-title":"Immunology"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110808_bib10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/imm.13336","article-title":"NLR family pyrin domain containing 3 (NLRP3) and caspase 1 (CASP1) modulation by intracellular Cl(-) concentration","volume":"163","author":"Clauzure","year":"2021","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110808_bib11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12950-015-0107-y","article-title":"CFTR knockdown induces proinflammatory changes in intestinal epithelial cells","volume":"12","author":"Crites","year":"2015","journal-title":"J. Inflamm."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110808_bib12","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1152\/physrev.00007.2018","article-title":"STRUCTURE, gating, and regulation of the CFTR anion channel","volume":"99","author":"Csan\u00e1dy","year":"2019","journal-title":"Physiol. Rev."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110808_bib13","article-title":"Alzheimer's disease drug development pipeline: 2023","volume":"9","author":"Cummings","year":"2023","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neuropharm.2025.110808_bib14","article-title":"Large\u2010scale proteome and metabolome analysis of CSF implicates altered glucose and carbon metabolism and succinylcarnitine in alzheimer's disease","author":"Daniel","year":"2023","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neuropharm.2025.110808_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/srep15946","article-title":"CFTR-regulated MAPK\/NF-kappaB signaling in pulmonary inflammation in thermal inhalation injury","volume":"5","author":"Dong","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2025.110808_bib16","article-title":"Cystic Fibrosis transmembrane conductance regulator andPseudomonas","author":"Edith","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110808_bib17","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.pharmthera.2007.06.006","article-title":"The role of amyloid beta peptide 42 in alzheimer's disease","volume":"116","author":"Findeis","year":"2007","journal-title":"Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110808_bib18","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1164\/rccm.202106-1426OC","article-title":"Trikafta rescues CFTR and lowers monocyte P2X7R-induced inflammasome activation in cystic fibrosis","volume":"205","author":"Gabillard-Lefort","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110808_bib19","doi-asserted-by":"crossref","first-page":"6668","DOI":"10.1038\/s41467-024-50641-1","article-title":"Allosteric inhibition of CFTR gating by CFTRinh-172 binding in the pore","volume":"15","author":"Gao","year":"2024","journal-title":"Nat. Commun."},{"issue":"5800","key":"10.1016\/j.neuropharm.2025.110808_bib20","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.1132814","article-title":"A century of alzheimer's disease","volume":"314","author":"Goedert","year":"2006","journal-title":"Science"},{"issue":"22","key":"10.1016\/j.neuropharm.2025.110808_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212256","article-title":"Modulation of neurolipid signaling and specific lipid species in the triple transgenic mouse model of alzheimer's disease","volume":"22","author":"Gonz\u00e1lez de San Rom\u00e1n","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"23","key":"10.1016\/j.neuropharm.2025.110808_bib22","doi-asserted-by":"crossref","first-page":"9776","DOI":"10.1021\/jm5012808","article-title":"Discovery of N-(2,4-di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (VX-770, ivacaftor), a potent and orally bioavailable CFTR potentiator","volume":"57","author":"Hadida","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2025.110808_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.570711","article-title":"The role of microglia and the Nlrp3 inflammasome in alzheimer's disease","volume":"11","author":"Hanslik","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuropharm.2025.110808_bib24","article-title":"Molecular cause and functional impact of altered synaptic lipid signaling due to a prg-1 gene SNP","author":"Johannes","year":"2015","journal-title":"EMBO Mol. Med."},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110808_bib25","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/NEN.0000000000000091","article-title":"Metabolomics of human brain aging and age-related neurodegenerative diseases","volume":"73","author":"Jov\u00e9","year":"2014","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"21","key":"10.1016\/j.neuropharm.2025.110808_bib26","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1093\/bioinformatics\/btn323","article-title":"ProteoWizard: open source software for rapid proteomics tools development","volume":"24","author":"Kessner","year":"2008","journal-title":"Bioinformatics"},{"key":"10.1016\/j.neuropharm.2025.110808_bib27","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3389\/fphys.2020.00879","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) in human lung microvascular endothelial cells controls oxidative stress, reactive oxygen-mediated cell signaling and inflammatory responses","volume":"11","author":"Khalaf","year":"2020","journal-title":"Front. Physiol."},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110808_bib28","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","article-title":"Graph-based genome alignment and genotyping with HISAT2 and HISAT-Genotype","volume":"37","author":"Kim","year":"2019","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110808_bib29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3233\/JAD-215699","article-title":"Alzheimer's disease: key insights from two decades of clinical trial failures","volume":"87","author":"Kim","year":"2022","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neuropharm.2025.110808_bib30","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.biocel.2016.02.022","article-title":"Targeted CFTR gene disruption with zinc-finger nucleases in human intestinal epithelial cells induces oxidative stress and inflammation","volume":"74","author":"Kleme","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110808_bib31","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1085\/jgp.201010518","article-title":"On the mechanism of CFTR inhibition by a thiazolidinone derivative","volume":"136","author":"Kopeikin","year":"2010","journal-title":"J. Gen. Physiol."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110808_bib32","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.neuroscience.2005.04.001","article-title":"Expression of somatostatin receptor subtypes (SSTR1-5) in alzheimer's disease brain: an immunohistochemical analysis","volume":"134","author":"Kumar","year":"2005","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110808_bib33","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Transl. Neurodegener."},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110808_bib34","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.neuropharm.2025.110808_bib35","article-title":"Small molecule modulators of cystic fibrosis transmembrane conductance regulator (CFTR): structure, classification, and mechanisms","author":"Lingfeng","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110808_bib36","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cell.2017.02.024","article-title":"Molecular structure of the human CFTR ion channel","volume":"169","author":"Liu","year":"2017","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110808_bib37","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110808_bib38","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1164\/rccm.201901-0145OC","article-title":"Correlating cystic fibrosis transmembrane conductance regulator function with clinical features to inform precision treatment of cystic fibrosis","volume":"199","author":"McCague","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110808_bib39","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1164\/rccm.201905-1013OC","article-title":"Specific inhibition of the NLRP3 inflammasome as an antiinflammatory strategy in cystic fibrosis","volume":"200","author":"McElvaney","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.neuropharm.2025.110808_bib40","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.coi.2020.10.011","article-title":"The NLRP3 inflammasome triggers sterile neuroinflammation and Alzheimer's disease","volume":"68","author":"Milner","year":"2021","journal-title":"Curr. Opin. Immunol."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110808_bib41","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00018-016-2390-z","article-title":"The gating of the CFTR channel","volume":"74","author":"Moran","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110808_bib42","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/s41588-020-0696-0","article-title":"An integrated multi-omics approach identifies epigenetic alterations associated with Alzheimer's disease","volume":"52","author":"Nativio","year":"2020","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110808_bib43","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb5398","article-title":"Molecular subtyping of Alzheimer's disease using RNA sequencing data reveals novel mechanisms and targets","volume":"7","author":"Neff","year":"2021","journal-title":"Sci. Adv."},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110808_bib44","doi-asserted-by":"crossref","first-page":"6040","DOI":"10.1128\/IAI.72.10.6040-6049.2004","article-title":"Bacterial overgrowth in the cystic fibrosis transmembrane conductance regulator null mouse small intestine","volume":"72","author":"Norkina","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.neuropharm.2025.110808_bib45","article-title":"Specific inhibition of the NLRP3 inflammasome as an antiinflammatory strategy in cystic fibrosis","author":"Oliver","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110808_bib46","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jcf.2025.04.003","article-title":"Cystic Fibrosis-related neurodegenerative disease associated with tauopathy and cognitive decline in aged CF mice","volume":"24","author":"Patton-Parfyonov","year":"2025","journal-title":"J. Cyst. Fibros. : Off J. European Cystic Fibrosis Soc."},{"key":"10.1016\/j.neuropharm.2025.110808_bib47","article-title":"Oxidative stress: the core pathogenesis and mechanism of Alzheimer's disease","author":"Renren","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neuropharm.2025.110808_bib48","article-title":"Substance P activates ADAM9 mRNA expression and induces \u03b1-secretase-mediated amyloid precursor protein cleavage","author":"Roberta","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110808_bib49","article-title":"IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosis","author":"Rossana","year":"2016","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110808_bib50","doi-asserted-by":"crossref","first-page":"770","DOI":"10.2174\/1568026620666200228095553","article-title":"Biological signatures of Alzheimer's disease","volume":"20","author":"Sharma","year":"2020","journal-title":"Curr. Top. Med. Chem."},{"issue":"10290","key":"10.1016\/j.neuropharm.2025.110808_bib51","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/S0140-6736(20)32542-3","article-title":"Cystic fibrosis","volume":"397","author":"Shteinberg","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2025.110808_bib52","article-title":"Integrative metabolomics science in Alzheimer's disease: relevance and future perspectives","author":"Simone","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110808_bib53","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1021\/ac051437y","article-title":"XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification","volume":"78","author":"Smith","year":"2006","journal-title":"Anal. Chem."},{"key":"10.1016\/j.neuropharm.2025.110808_bib54","article-title":"Alterations of substance P metabolism and neuropeptidases in Alzheimer's disease","author":"Stephen","year":"1995","journal-title":"J. Geront. Series A, Biol. sci. Med. Sci."},{"key":"10.1016\/j.neuropharm.2025.110808_bib55","article-title":"What to know about the alzheimer drug aducanumab (Aduhelm)","author":"Steven","year":"2022","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.neuropharm.2025.110808_bib56","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3389\/fphar.2015.00221","article-title":"beta-Amyloid: the key peptide in the pathogenesis of Alzheimer's disease","volume":"6","author":"Sun","year":"2015","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110808_bib57","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1471-4159.2010.07157.x","article-title":"Understanding the pathogenesis of Alzheimer's disease: will RNA-Seq realize the promise of transcriptomics?","volume":"116","author":"Sutherland","year":"2011","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110808_bib58","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s12035-013-8475-x","article-title":"The NLRP3 inflammasome in Alzheimer's disease","volume":"48","author":"Tan","year":"2013","journal-title":"Mol. Neurobiol."},{"issue":"10408","key":"10.1016\/j.neuropharm.2025.110808_bib59","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0140-6736(23)01609-4","article-title":"CFTR modulator therapy: transforming the landscape of clinical care in cystic fibrosis","volume":"402","author":"Taylor-Cousar","year":"2023","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110808_bib60","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13024-023-00674-9","article-title":"Microglial function, INPP5D\/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer's disease","volume":"18","author":"Terzioglu","year":"2023","journal-title":"Mol. Neurodegener."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110808_bib61","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/hup.823","article-title":"The G51S purine nucleoside phosphorylase polymorphism is associated with cognitive decline in Alzheimer's disease patients","volume":"22","author":"Tumini","year":"2007","journal-title":"Hum. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110808_bib62","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41582-022-00749-z","article-title":"Synaptic degeneration in Alzheimer disease","volume":"19","author":"Tzioras","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2025.110808_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104384","article-title":"Restoring myocardial infarction-induced long-term memory impairment by targeting the cystic fibrosis transmembrane regulator","volume":"86","author":"Vanherle","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.neuropharm.2025.110808_bib64","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.conb.2021.03.003","article-title":"A current view on Tau protein phosphorylation in Alzheimer's disease","volume":"69","author":"Wegmann","year":"2021","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2025.110808_bib65","article-title":"Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression","author":"Xinyi","year":"2019","journal-title":"Cell Res."},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110808_bib66","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s10571-017-0471-7","article-title":"Upregulated expression of SSTR3 is involved in neuronal apoptosis after intracerebral hemorrhage in adult rats","volume":"37","author":"Yao","year":"2017","journal-title":"Cell. Mol. Neurobiol."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110808_bib67","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110808_bib68","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s10495-014-1014-z","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) prevents apoptosis induced by hydrogen peroxide in basilar artery smooth muscle cells","volume":"19","author":"Zeng","year":"2014","journal-title":"Apoptosis"},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110808_bib69","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00109-018-1649-2","article-title":"CFTR prevents neuronal apoptosis following cerebral ischemia reperfusion via regulating mitochondrial oxidative stress","volume":"96","author":"Zhang","year":"2018","journal-title":"J. Mol. Med. (Berl.)"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825005167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825005167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T13:05:49Z","timestamp":1773925549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390825005167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":69,"alternative-id":["S0028390825005167"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110808","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cftr nominates a novel therapeutic target for Alzheimer's disease: Evidence from integrative omics and in vitro validation","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110808","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110808"}}